MYD88 and ovarian cancer: MyD88 positive EOCs have a functioning TLR4/MyD88 pathway and may represent an ovarian cancer stem cell (CSC) that is highly resistant to pro-apoptotic signaling and which can recruit leukocytes to actively promote a pro-inflammatory, pro-proliferative microenvironment [22].